Antonio Dávalos Selected Research

Antonio Dávalos Research Topics

Disease

15	Stroke (Strokes) 01/2022 - 05/2002
13	Ischemic Stroke 01/2022 - 08/2002
5	Infarction (Infarctions) 02/2009 - 03/2003
3	Brain Ischemia (Cerebral Ischemia) 01/2022 - 04/2008
3	Brain Edema (Cerebral Edema) 07/2008 - 09/2005
3	Hypertension (High Blood Pressure) 01/2006 - 05/2002
3	Lacunar Stroke 01/2006 - 05/2002
2	Hyperglycemia 10/2010 - 03/2003
2	Brain Injuries (Brain Injury) 07/2008 - 03/2003
2	Inflammation (Inflammations) 01/2006 - 10/2005
2	Cerebral Infarction 12/2003 - 03/2003
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2013
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2012
1	Edema (Dropsy) 01/2007
1	Hematoma 01/2007
1	Iron Overload 01/2007
1	Headache (Headaches) 10/2005
1	Hypothermia 09/2005
1	Ischemia 12/2003
1	Disease Progression 03/2003
1	Hyperthermia 03/2003
1	Hyperlipidemias (Hyperlipidemia) 05/2002

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 06/2013 - 10/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2006 - 05/2002
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2007
2	Interleukin-10 (Interleukin 10)IBA 06/2013 - 03/2003
2	Glucose (Dextrose)FDA LinkGeneric 02/2009 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005 - 12/2003
2	InterleukinsIBA 12/2003 - 03/2003
2	CytokinesIBA 03/2003 - 05/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Anabolic Androgenic SteroidsIBA 03/2013
1	Insulin (Novolin)FDA Link 10/2010
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2009
1	Proteins (Proteins, Gene)FDA Link 08/2009
1	HaptoglobinsIBA 08/2009
1	Atrial Natriuretic Factor (ANF)IBA 01/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2009
1	Endothelin-1 (Endothelin 1)IBA 07/2008
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 07/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008
1	N-Methylaspartate (NMDA)IBA 04/2008
1	Glutamic Acid (Glutamate)FDA Link 04/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2008
1	erucylphosphocholineIBA 10/2007
1	Ferritins (Ferritin)IBA 01/2007
1	IronIBA 01/2007
1	Neuroprotective AgentsIBA 06/2005
1	9-deoxy-delta-9-prostaglandin D2IBA 06/2005
1	ProstaglandinsIBA 06/2005
1	Interleukin-4 (Interleukin 4)IBA 03/2003
1	Heparin (Liquaemin)FDA LinkGeneric 08/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2002

Therapy/Procedure

6	Therapeutics 01/2019 - 09/2005
3	Thrombectomy 01/2022 - 01/2014
2	Thrombolytic Therapy 01/2019 - 01/2007
1	Embolectomy 01/2021
1	Contraindications 01/2014
1	Secondary Prevention 10/2012
1	Aftercare (After-Treatment) 01/2007